Correlation between Circadian Gene Variants and Serum Levels of Sex Steroids and Insulin-like Growth Factor-I
Open Access
- 1 November 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 17 (11) , 3268-3273
Abstract
A variety of biological processes, including steroid hormone secretion, have circadian rhythms, which are influenced by nine known circadian genes. Previously, we reported that certain variants in circadian genes were associated with risk for prostate cancer. To provide some biological insight into these findings, we examined the relationship of five variants of circadian genes, including NPAS2 (rs2305160:G>A), PER1 (rs2585405:G>C), CSNK1E (rs1005473:A>C), PER3 (54-bp repeat length variant), and CRY2 (rs1401417:G>C), with serum levels of sex steroids and insulin-like growth factor (IGF)-I and IGF-binding protein 3 (IGFBP3) in 241 healthy elderly Chinese men (mean age of 71.5). Age-adjusted and waist-to-hip ratio–adjusted ANOVA followed by likelihood ratio tests (LRT) showed that the NPAS2 variant A allele was associated with lower free and bioavailable testosterone (PLRT = 0.02 and 0.01, respectively) compared with the GG genotype. In addition, the PER1 variant was associated with higher serum levels of sex hormone-binding globulin levels (Ptrend = 0.03), decreasing 5α-androstane-3α, 17β-diol glucuronide levels (Ptrend = 0.02), and decreasing IGFBP3 levels (Ptrend = 0.05). Furthermore, the CSNK1E variant C allele was associated with higher testosterone to dihydrotestosterone ratios (PLRT = 0.01) compared with the AA genotype, whereas the longer PER3 repeat was associated with higher serum levels of IGF-I (PLRT = 0.03) and IGF-I to IGFBP3 ratios (PLRT = 0.04). The CRY2 polymorphism was not associated with any biomarkers analyzed. Our findings, although in need of confirmation, suggest that variations in circadian genes are associated with serum hormone levels, providing biological support for the role of circadian genes in hormone-related cancers. (Cancer Epidemiol Biomarkers Prev 2008;17(11):3268–73)Keywords
This publication has 34 references indexed in Scilit:
- Does early morning versus late morning draw time influence apparent testosterone concentration in men aged ⩾45 years? Data from the Hypogonadism In Males studyInternational Journal Of Impotence Research, 2007
- Growth hormone regulation of metabolic gene expression in muscle: a microarray study in hypopituitary menAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer riskBreast Cancer Research and Treatment, 2007
- Molecular epidemiology of prostate cancer: hormone-related genetic lociFrontiers in Bioscience-Landmark, 2007
- Ala394Thr polymorphism in the clock gene NPAS2: A circadian modifier for the risk of non‐Hodgkin's lymphomaInternational Journal of Cancer, 2006
- A haplotype map of the human genomeNature, 2005
- Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysisThe Lancet, 2004
- Hormones and prostate cancer: Current perspectives and future directionsThe Prostate, 2002
- Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGF-II in untreated and treated acromegaly and growth hormone deficiencyClinical Endocrinology, 2000
- Diurnal variation in serum insulin‐like growth factor (IGF)‐I and IGF binding protein‐3 concentrations during daily subcutaneous injections of recombinant human growth hormone in GH‐deficient adultsClinical Endocrinology, 1997